Results for tag: "Belimumab"

Belimumab is a monoclonal antibody used to treat certain immune disorders. It is used to treat systemic lupus erythematosus (SLE), an autoimmune disorder that affects the skin, joints, and organs. Belimumab works by blocking the action of a protein called B-lymphocyte stimulator (BLyS), which is involved in the production of autoantibodies. This helps to reduce the symptoms of SLE, such as fatigue, joint pain, and skin rashes. Belimumab is administered as an intravenous infusion and is usually given once a month. Belimumab is a relatively new drug and is still in the early stages of development. It is currently approved for use in the United States, Europe, and other countries. Clinical trials are ongoing to evaluate its efficacy and safety in other immune disorders. Several companies are involved in the development and marketing of belimumab. These include GlaxoSmithKline, Human Genome Sciences, and Bristol-Myers Squibb. Show Less Read more